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Abstract
Background: For allergic disorders, the increasing prevalence over the past decade has been
attributed in part to the lack of microbial burden in developed countries ('hygiene hypothesis').
Variation in genes encoding toll-like receptors (TLRs) as the receptor system for the first innate
immune response to microbial stimuli has been implicated in various inflammatory diseases. We
evaluated here the role of a coding variation, Ser249Pro, in the TLR6 gene in the pathogenesis of
asthma, atopic dermatitis (AD) and chronic obstructive pulmonary disease (COPD).
Methods: Genotyping of the Ser249Pro polymorphism in 68 unrelated adult patients and 132
unrelated children with asthma, 185 unrelated patients with COPD, 295 unrelated individuals with
AD and 212 healthy control subjects was performed by restriction enzyme digestion.
Results: We found a weak association of the 249Ser allele with childhood asthma (p = 0.03). Yet,
significance was lost after Bonferroni correction. No association was evident for AD or COPD.
Conclusion: Variation in TLR6 might play a role in the pathogenesis of childhood asthma.
Background
Asthma, atopic dermatitis (AD) and chronic obstructive
pulmonary disease (COPD) are common chronic inflam-
matory diseases with prevalence rates between 5 and 15%,
making them major public-health problems worldwide
[1,2]. For all three diseases, a multifactorial background
has been suggested with genetic as well as environmental
factors influencing disease susceptibility [3-5]. There is
now strong evidence that exposure to microbial products
in early childhood plays an important role in the postna-
tal maturation of the immune system and that the
increase in the prevalence of allergic diseases over the last
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bial burden in industrialized countries (the so-called
hygiene hypothesis) [6,7]. The receptor system that con-
stitutes the first, innate immune response to microbial
stimuli consists of the family of toll-like receptors (TLRs),
highly conserved receptor complexes that recognize path-
ogen-associated molecular patterns (PAMPs) [8]. Cur-
rently, 10 different TLRs are known each of which
recognizes a different spectrum of PAMPs. As activators of
cytokine production in response to infections, TLRs are
believed to be involved in the establishment of T helper
(Th)1 immune responses in early life, counter-balancing
the Th2-dominated cytokine spectrum at birth [9].
Genetic variation in these receptors could thus influence
susceptibility for both Th1- (e.g., autoimmune) and Th2-
mediated (e.g., allergic) diseases [9].
While several studies have evaluated the role of variation
in TLR4, the receptor for endotoxin, for allergic diseases
[10-12], little is known about the role of TLR6 variation so
far. TLR6 forms heterodimers with TLR2 for recognition of
bacterial lipopeptides [13]. Expression of TLR6 has been
demonstrated in human mast cells [14] which play an
important role in allergic diseases [15]. Interestingly, acti-
vation of mast cells via, both, TLR4 and TLR2/TLR6
resulted in additive effects on cytokine production [16].
Thus, TLR6 appears as interesting candidate gene for aller-
gic disorders. The TLR6 gene is located on chromosome
4p13 and it comprises a single exon encoding a 796
amino-acid polypeptide. Recently, a common coding pol-
ymorphism was identified in this gene that leads to an
exchange from serine to proline at position 249 in the
extracellular domain of the TLR6 protein [17]. In prelimi-
nary analyses, the T allele (249Ser) was associated with
protection from asthma in African American samples,
while the same trend was not significant for European
Americans [17]. Although the association reported in this
study is intriguing considering the hygiene hypothesis, a
replication of this finding for asthma in a different sample
has not yet been accomplished. We further speculated that
TLR6 coding variation might also play a role in the patho-
genesis of COPD since it is – like asthma – a common
chronic lung disease characterized by chronic airway
inflammation and airway hyper-responsiveness [1]. In
addition, there is growing evidence that at least part of the
genetic background might be common among COPD and
asthma [18]. We therefore studied the TLR6 Ser249Pro
polymorphism in four different German cohorts: adult
asthmatics, pediatric asthmatics, patients with COPD and




185 unrelated adult patients with COPD and 68 unrelated
adult patients with asthma were recruited while hospital-
ized at the Bergmannsheil clinics, Ruhr-University
Bochum, Germany, and 132 unrelated children with
asthma in the Pediatric Pneumology Studycenter (PPS)
located at the same place. The COPD diagnosis was based
on the classification of the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) criteria [19]. Patients
included in the study had at least a forced expiratory vol-
ume in one second (FEV1) of < 80% of predicted and a
FEV1/FVC (forced vital capacity) ratio of < 70% of pre-
dicted, classified as moderate to severe COPD (GOLD
stages II-IV). Adult asthmatics had a doctor's diagnosis of
asthma according to the standards of the American Tho-
racic Society [20]. The exclusion criteria were α1-antit-
rypsin deficiency, dyspnea of other origin (including
cardiovascular disorders, pneumonia, interstitial lung dis-
ease, pleural disease, upper airways obstruction, neu-
romuscular disease and anaemia) and bronchial
carcinoma. For the asthmatic children, the asthma diag-
nosis was based on the ISAAC questionnaire [21]. Disease
severity was assessed by a symptom score recently vali-
dated [22]. 294 unrelated patients with AD were recruited
by a consultant specialist for AD (QP, Gladbeck, Ger-
many), including 175 children and 119 adults. The AD
diagnosis was based on the presence of clinical features,
including purities, eczema with age-dependent differences
in location, xerosis and chronic or relapsing dermatitis. In
addition, all investigated AD patients had a positive fam-
ily history for atopic diseases.
Table 1: Clinical data of the asthma, AD and COPD cohorts as well as the control group
Adult patients with 
asthma
Children with asthma AD COPD Healthy controls
number of subjects 68 132 294 182 212
gender: f/m 36/32 52/80 180/114 62/120 131/81
age (years) [median(range)] 38 (18–68) 9.5 (2–15) 12 (0.5–72) 68 (33–81) 59 (22–87)
FEV1 (%pred.) (mean ± STD) 73 ± 25 97 ± 18 -- 47 ± 19 --
FEV1/FVC ratio (mean ± STD) 65 ± 16 98 ± 15 -- 49 ± 15 --
pack years [median(range)] 2 (0–44) -- -- 30 (0–200) --Page 2 of 6
(page number not for citation purposes)
BMC Medical Genetics 2005, 6:34 http://www.biomedcentral.com/1471-2350/6/34212 control samples from adults without known allergies,
asthma or AD were collected in the same private practice
as the AD patients. We specifically chose to use non-aller-
gic adults as controls because for diseases as frequent as
asthma and AD, the risk remains very high for asympto-
matic children to develop an allergic disease during child-
hood or even adulthood [23,24]. The control subjects
underwent clinical examination in order to exclude symp-
toms of asthma, AD or COPD, had no self-reported aller-
gies or allergic symptoms and no first degree relatives with
known allergic diseases. Lung function tests or IgE meas-
ures were not performed for the controls. All patient and
control subjects were Caucasians of German origin.
Informed consent was obtained from all subjects. The
study was approved by the Ethics Committee of the Uni-
versity of Bochum and the Declaration of Helsiniki proto-
cols were followed. DNA was extracted from EDTA anti-
coagulated peripheral blood by using a standard salting-
out method [25].
Genotyping
Genotyping of the TLR6 Ser249Pro polymorphism was
performed by polymerase chain reaction (PCR) with sub-
sequent restriction enzyme digestion. PCR reactions were
performed in a total volume of 10 µl, containing 50 ng
DNA, 200 mmol of each dNTP, 3 mmol MgCl2, 10 pmol
of each primer (forward: GCATTTCCAAGTCGTTTC-
TATGT; reverse: GCAAAAACCCTTCACCTTGTT), and 0.4
U Taq polymerase (Genecraft, Münster, Germany). Ther-
mal cycling was performed (Biometra, Göttingen, Ger-
many). After two initial cycles at 6°C and 3°C above the
annealing temperature, 27 cycles of 95°C (30 sec), 57°C
(60 sec) and 72°C (60 sec) were run. The PCR product
was digested with Ava II (0.01 U/ng DNA) at 37°C for
three hours. The fragments were subsequently separated
on 2% agarose gels in 1 × TBE buffer (30 min, 200 V) and
visualized using ethidium bromide staining.
Statistical analyses
Genotype and allele frequencies were ascertained by direct
counting and subsequently analyzed according to the χ2
method. Deviations from Hardy-Weinberg equilibrium
were evaluated using the FINETTI program. P < 0.05 was
considered to be significant. Power calculations were per-
formed using the Power and sample size program [26].
Results and discussion
Clinical data concerning the four patient groups are sum-
marized in table 1. Since the nucleotide substitution from
C to T at position 744 in the TLR6 gene results in the cre-
ation of a new restriction site, the Ser249Pro polymor-
phism was genotyped by restriction enzyme digestion.
Genotype frequencies for case and control groups are
shown in table 2. The frequencies in all five groups were
in Hardy-Weinberg equilibrium. There was a significant
association between the T allele (249Ser) and childhood
asthma (p = 0.03, table 3). Yet, significance was lost after
Bonferroni correction. For the other three case groups, no
significant association was observed.
Although it seems puzzling to identify the opposite allele
being associated with childhood asthma as compared to
the one reported by Tantisira et al. [17], there are plausible
explanations for this phenomenon. First, the association
with childhood asthma reported here is only a weak asso-
ciation that did not withstand Bonferroni correction. Yet,
we consider the study to be explorative and hypothesis-
generating and find the results intriguing in the light of
the emerging role of TLRs in allergic diseases [9]. In addi-
tion, the reported association refers to a coding variation
that might at least theoretically have functional conse-
quences. It remains largely unknown what sort of genetic
variants explain inherited variation in complex traits, but
recent evidence suggests that common, non-coding
genetic variants will explain at least some of the inherited
variation in susceptibility to common disease [27]. Thus,
testing a single functional variation would be more likely
biased into the direction of a negative result rather than of
a positive association.
Second, the previous association of the 249Ser allele with
protection from asthma was defined in a sample of Afri-
Table 2: Genotype frequencies of the TLR6 Ser249Pro polymorphism in the case and control groups.
TLR6 Ser249Pro Controls Asthma adults Asthma children AD COPD
N = 212 N = 68 N = 132 N = 294 N = 185
Pro/Pro 75 28 32 108 76
Pro/Ser 104 32 72 138 80
Ser/Ser 33 8 28 48 29
p-value - n.s. 0.07 n.s. n.s.Page 3 of 6
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quency of the Ser249Pro polymorphism in this cohort
was 0.08 in asthmatics and 0.19 in controls [17] and thus
much lower than in our four German cohorts with a
minor allele frequency of on average 0.40 (range 0.35 to
0.49). Yet, the allele frequencies we observed in this study
are comparable to the ones for European Americans [28].
It appears possible that the Ser249Pro polymorphism
might not be disease-causing by itself, but instead be in
linkage disequilibrium with the true disease-causing vari-
ation. In this case, different alleles of Ser249Pro could be
linked to the relevant allele in different populations (e.g.,
African Americans and Caucasians). Further association
studies in these and other populations are needed to
answer this question.
Third, environmental factors might play a role in disease
susceptibility associated with opposite alleles. One such
example has been described for CD14, which associates
with TLR4 to form the receptor complex that recognizes
lipopolysaccharide (LPS, endotoxin). A single nucleotide
polymorphism (SNP) in the CD14 promoter at position -
159 (C/T) was identified [29]. The -159T allele was asso-
ciated with high levels of soluble CD14 and decreased
total serum IgE in a cohort of children from Tucson, Ari-
zona [29]. Yet, no association of this SNP with allergy or
IgE levels was evident in a large German cohort [30]. In
the Hutterites, an isolated population from South Dakota,
the -159T allele was instead associated with increased risk
for atopy [31]. Vercelli recently postulated an intriguing
explanation for this phenomenon: she suggested that the
level of endotoxin exposure influences the 'switch' from
the Th2-biased cytokine profile at birth to a Th1-biased
cytokine profile in early childhood, and that endotoxin
levels might interact with the CD14 genotype to confer
either risk to or protection from atopic phenotypes later in
life [32]. Thus, environmental factors – and even endo-
toxin load – might also be responsible for the discrepancy
between the findings of Tantisira et al. [17] and our
results, concerning the role of the Ser249Pro polymor-
phism in asthma pathogenesis. Since we did not yet meas-
ure endotoxin levels, we are unable to explore this
question at the moment.
Association studies of polymorphisms in other TLR genes
have also revealed somewhat contradictory results. Two
missense mutations (Asp299Gly and Thr399Ile) in the
gene encoding TLR4 which mediates the biological
response to LPS were associated with a decreased response
to inhaled endotoxin in humans [33]. Since exposure to
LPS in early life has been suggested to exert protective
effects on the development of allergic diseases [34-36],
the TLR4 gene appeared to be an outstanding functional
candidate for the susceptibility to asthma and allergic dis-
eases. Yet only one out of four association studies found a
direct association of the TLR4 Asp299Gly polymorphism
with asthma [10]. In three other studies, no differences in
the overall risk for asthma between carriers of the wild
type and mutant genotypes were obvious [11,12,37]. On
the other hand, an impact of this polymorphism on the
severity of atopy in asthmatics [11] was reported as well as
a modified response to endotoxin [12], indicating gene/
environment interplay. Similarly, a polymorphism at
position -16934 in the TLR2 gene was significantly associ-
ated with asthma and atopy in farmers' children but not
in children that did not grow up on farms [38], pointing
again to a gene/environment interaction. Thus, variation
in TLR genes appears to have modifying effects on asthma
susceptibility.
The fact that we did not find an association of the
Ser249Pro polymorphism with adult asthma might be
due to the small sample size of adult asthmatics. Yet, in
order to achieve a significance level of 0.05 with a
statistical power of 80%, a sample size of over 500
patients would have been required. Replication studies in
larger cohorts as well as functional studies are clearly
needed. To our knowledge, this is the first evaluation of
the TLR6 Ser249Pro polymorphism in patients with
atopic dermatitis, and we did not find association with
this allergic skin disease, suggesting that the observed
association might be restricted to (childhood) asthma,
rather than allergic diseases in general. This finding is not
totally unexpected since the results of genome-wide
screens indicate that loci linked to AD do not overlap sub-
stantially with loci linked to asthma and related pheno-
types, but rather with loci for psoriasis, another chronic
skin disease [4]. Furthermore, we did not find evidence
that TLR6 Ser249Pro contributes to susceptibility for
COPD.
Conclusion
We found a weak association between the TLR6
Ser249Pro polymorphism and risk for childhood asthma,
while no association was evident for AD or COPD. Analy-
sis of the effect of this variation on disease severity and
potential gene/environment interactions might be a
promising approach since gene/environment interactions
have been described for other TLR genes. Further studies
Table 3: Allele frequencies of the TLR6 Ser249Pro polymorphism 





Pro 136 (51.5%) 254 (59.9%)
Ser 128 (48.5%) 170 (40.1%)
p = 0.03Page 4 of 6
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defined cohorts as well as functional studies of this varia-




COPD chronic obstructive pulmonary disease
FEV1 forced exspiratory volume in the first second
FVC forced vital capacity
LPS lipopolysaccharide
PAMP pathogen-associated molecular pattern
PCR polymerase chain reaction
TLR toll-like receptor
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